This document provides information on Raynaud's disease, including its definition, causes, risk factors, clinical manifestations, diagnosis, and treatment. Raynaud's is a condition characterized by reduced blood flow to the extremities (fingers and toes) in response to cold or stress. It involves painful color changes from white to blue to red as vessels constrict and dilate. The document outlines diagnostic tests like cold stimulation and nailfold capillaroscopy. Medical management focuses on lifestyle changes and medications like calcium channel blockers to prevent vasospasm. Nursing management aims to minimize sensory changes, relieve pain, and provide patient education.
This is a topic from cardiovascular system which includes definition, risk factors, pathophysiology, clinical menifestation, diagnostic evaluation and management
CARDIAC TAMPONADE ( Cardiac emergency) • Cardiac Tamponade is a life threatening complication caused by excessive accumulation of fluid in the pericardium. Or • Compression of all cardiac chambers due to excessive accumulation of pericardial fluid leading to compromised cardiac out put.
Rheumatic heart disease is a condition in which the heart valves have been permanently damaged by rheumatic fever. The heart valve damage may start shortly after untreated or under-treated streptococcal infection such as strep throat or scarlet fever.
This is a topic from cardiovascular system which includes definition, risk factors, pathophysiology, clinical menifestation, diagnostic evaluation and management
CARDIAC TAMPONADE ( Cardiac emergency) • Cardiac Tamponade is a life threatening complication caused by excessive accumulation of fluid in the pericardium. Or • Compression of all cardiac chambers due to excessive accumulation of pericardial fluid leading to compromised cardiac out put.
Rheumatic heart disease is a condition in which the heart valves have been permanently damaged by rheumatic fever. The heart valve damage may start shortly after untreated or under-treated streptococcal infection such as strep throat or scarlet fever.
The sensation of cold hands is a common complaint, especially in chilly weather. However, for some individuals, this discomfort is more than just a response to the environment. It might be an indication of a condition known as Raynaud’s phenomenon. In this article, we will explore the world of cold hands, and understand what Raynaud’s phenomenon is, its causes, symptoms, diagnosis, and management.
Raynaud's disease, also known as Raynaud's phenomenon or Raynaud's syndrome, is a condition that affects blood flow to certain parts of the body—usually the fingers and toes. In Raynaud's disease, smaller arteries that supply blood to the skin constrict excessively in response to cold or stress, limiting blood supply to affected areas (vasospasm). This can lead to numbness, tingling, and color changes in the affected areas, typically turning them white or blue.
Raynaud’s Phenomenon used to describe episodic events which represent vasoconstriction of digital arteries, precapillary arterioles and arteriovenous shunts.
Raynauds syndrome is an episodic vasospasm, i.e. arteriolar spasm. It leads to sequence of clinical features called as Raynaud’s syndrome.
episodic attacks of well demarcated reversible self limiting colour changes for 1–20 minutes on exposure to cold/emotional stimuli and is symmetrical/bilateral lasting for 2 years”.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Artificial Intelligence to Optimize Cardiovascular Therapy
Slide for raynaud's disease
1. RELIANCE INSTITUTE OF
NURSING LIMTARA
DHAMTARI (C.G)
TOPIC - RAYNAUD’S
DISEASE
• PRESENTED BY-
• OM VERMA
• ASSISTANT PROFESSOR
2.
3. Raynaud’s disease
Raynaud’s phenomenon is
a form of intermittent
arteriolar vasoconstriction
that results in coldness,
pain & pallor of the
fingertips or toes.
There are 2 forms of this
disorders :-
1. Primary or idiopathic
Raynaud’s disease
2. Secondary Raynaud’s
syndrome
4. Definition
“Raynaud's phenomenon (RP) is a
condition resulting in a particular series of
discolorations of the fingers and/or the
toes after exposure to changes in
temp.(cold or hot) or emotional events.
Skin discoloration occurs b’coz an
abnormal spasm of the blood vessels
causes a diminished blood supply
to the local tissues.”
according to luck man.s
5. According to joyce M black
The Raynaud’s phenomenon is
used to refer to localized,
intermittent episodes of
vasoconstriction of small arteries of
the feet and hands that cause color
and temperature changes
6. According to lippin cott
• It is a recurrent vasospasm of the
fingers and toes and usually occurs
in response to stress or cold
exposure
7. Incidence
Raynaud’s disease is
most common in women between 16
& 40 yrs. Of age & it occurs more
frequently in cold climates & during
the winter.
8. • CLASSIFICATION
• • Primary
• occurrence of the vasospasm alone,
with no association with another illness
• • Secondary
• secondary to other conditions, most
commonly an autoimmune disease
• eg- SLE, rhematoid arthrits
9. Etiology
1) Primary Raynaud’s disease :-(symptoms
are idiopathic)
Hereditary
Smoking worsens frequency and intensity of
attacks & there is a hormonal component.
Caffeine
2) Secondary Raynaud’s (Syndrome) :-
Connective tissue disorders
Eating disorders
Obstructive disorders
Drugs
Occupation
Others
10. • Working with vibrating machinery - the
fingers may go into spasm. This is due
to an intermittent lack of blood supply
to the fingers.
• o Emotional distress
• o Exposure to the cold
• • Exposure to chemicals such as PVC,
Silica.
• • Smoking
• • Autoimmune disease
11. Risk factors
1) The risk factors for primary Raynaud's include :-
Gender,Age,Family history & Living in a cold climate
2) The risk factors for secondary Raynaud's include
:-
Age
Certain diseases and conditions
Injuries to the hands or feet
Exposure to certain workplace chemicals
Repetitive actions with the hands
Certain medicines
Smoking
Living in a cold climate
12.
13. Clinical manifestation
1. Intermittent arteriolar vasoconstriction resulting in
coldness, pain, pallor.
2. Involvement of the fingers appears to be asymmetric;
thumbs are less often involved.
3. Characteristic color changes: white-blue-red.
a) White- blanching, dead-white appearance if spasm is
severe
b) Blue - cyanotic,because of pooling of deoxygenated
blood during vasospasm.
c) Red – because of oxygenated blood
returns to the digits after the
vasospasm stops.
4. Occasionally,ulceration of the fingertips.
5. Numb, prickly feeling or stinging pain
upon warming or relief of stress.
14. • Signs and Symptoms
• • The attacks can affect the fingers and toes,
and rarely the nose, ears,or lips.
• • The affected body parts will usually have two
or more of the following changes:
• • Look pale due to lack of blood flow
• • Look bluish due to a lack of oxygen
• • Feel numb, cold, or painful
• • Redden as blood returns to the affected area
15. • Patients often describe 3 phases
of change –
• • initial white (vasoconstriction),
• • followed by blue (cyanosis),
• • then red (rapid blood reflow
16. Diagnostic evaluation
1. History taking
2. Physical examination
3. Cold Stimulation Test
4. Nail-fold Capillaroscopy
5. Digital artery pressure
6. Doppler ultrasound
7. Complete blood count
8. Blood test for urea & electrolytes
9. Thyroid function tests
10.An auto-antibody screen tests
17. • Diagnosis
• • History collection
• Obtain a history of injury or frostbite
• occupational history eg- jackhammers
• Industrial exposure to polyvinyl chloride
• Autoimmune disorders
• • Physical examination
• observe the colur of digits, ulcers
• Examine nailfold capillaries under magnification help
• diagnose underlying autoimmune disorders
18. • Laboratory investigation
• Complete blood count
• ESR
• Antinuclear antibody - May be positive
in autoimmune disorders and should be
obtained in patients with features of these
disorders.
• Rheumatoid factor - May be elevated in
• rheumatoid arthritis, other autoimmune
disorders
19. • History taking :-Clinical symptoms must
last atleast 2 yrs. To confirm the
diagnosis.& Ask about the risk factors of
the disease.
• Physical examination :- Check the finger &
toes for blood circulation.
20. • Cold Stimulation Test :-A cold stimulation
test can be used to trigger Raynaud's
symptoms.For this test,a small device that
measures temperature is taped to
fingers.hands are then exposed to cold—
they're usually briefly put into ice
water.hands are then removed from the
cold & the device measures how quickly
fingers return to their normal
temperature.If you have Raynaud's,it may
take more than 20 minutes for fingers to
return to their normal temperature.
21. • Nail-fold Capillaroscopy :-For this
test,doctor puts a drop of oil at the base of
fingernail.He or she then looks at
fingernail under a microscope.If doctor
sees abnormal arteries,it may mean you
have a disease linked to Raynaud's.
• Digital artery pressure :- pressures are
measured in the arteries of the fingers
before and after the hands have been
cooled. A decrease of at least 15 mmHg is
diagnostic (positive).
• Doppler ultrasound :-to assess blood flow.
22. • Complete blood count :- this can
reveal a
normocytic anemia suggesting
the anemia or renal failure
23. • Blood test for urea and electrolytes:-
this can reveal renal impairment.
• Thyroid function tests :- this can
reveal hypothyroidism.
• An auto-antibody screentests:-
for rheumatoid factor,Erythrocyte
sedimentation rate and C-reactive
protein,which may reveal specific
causative illnesses or a generalised
inflammatory process.
24. • Medical Management
• • Avoiding the particular stimuli (eg, cold,
tobacco)
• that provoke vasoconstriction
• • Calcium channel blockers
• eg- Nifidipine
• 30-120 mg of the extended-release
• formulation taken once daily
• • Topical nitroglycerin (1% or 2%)
25. • Medical management :-
• Avoiding the particular stimuli such as cold
&tobacco,that provoke vasoconstriction is a primary
factor in controlling Raynaud's phenomenon.
• Longer acting calcium channel blocker such as
Nifedipine, Amlodipine may be used to prevent
vasospasm.
• Antiplatelet agents such as Aspirin or Dipyridamole
(persantine) may be given to prevent total occlusion.
• Sympathectomy (interrupting the sympathetic nerves
by removing the sympathetic ganglia or dividing their
branches) such as Reserpine (serpasil),Guanethidine
or Prazosin may be helpful.
•
26. • Nursing Management
• • The client is encouraged to avoid exposure
to cold.
• • Avoid repetitive hand movements and
stressful situations.
• • Quit smoking and avoids secondary smoke
as nicotine is potent vasoconstrictor.
• • Stress management techniques ex.
biofeedback
• • Assist in alleviating some distress from the
condition
28. Medical management
1. Avoiding particular stimuli
i.e. cold & tobacco
2. Calcium channel blocker
such as Nifedipine,
Amlodipine may be used
3. Antiplatelet agents such as
Aspirin may be used.
4. Sympathectomy may be
helpful.
29. Alternative & experimental approaches
1. The Ayurvedic oil preparation Mahanarayan
Oil has been used very successfully in many
cases as a vasodilater when applied daily to
affected areas.
2. Two separate gels combined on the fingertip
increased blood flow in the fingertips by
about three times.One gel contained 5%
sodium nitrite and the other contained 5%
ascorbic acid.The milliliter of combined gel
covered an area of 3 cm².The gel was wiped
off after a few seconds.
3. Fish oil supplements which contain long-
chain omega-3 fatty acids may help to
control symptoms of primary Raynaud's.